MedTrace Logo

CBT-based and Motivational Interviewing Supported Psychoeducation in Obese Individuals

NCT06632171 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2026-03-03

No results posted yet for this study

Summary

The aim of this study is to examine the effects of cognitive-behavioral and motivational interview-supported psychoeducation on emotional eating and psychological resilience in obese individuals. The study will be conducted with a randomized controlled experimental design. The sample of the study will consist of 102 obese individuals in total, 51 in the experimental group and 51 in the control group, who meet the inclusion criteria. A cognitive-behavioral and motivational interview-supported psychoeducation program will be applied to the experimental group. All patients will be evaluated at three time points: pre-test (baseline), post-test (8 weeks), and follow-up test (3 months after the post-test). No intervention will be applied to the control group. The Emotional Eating Scale and Psychological Resilience Scale will be used as data collection tools in the study. As a result of the study, the hypothesis that the cognitive-behavioral and motivational interview-supported psychoeducation program is effective in reducing the emotional eating levels of obese individuals and increasing their psychological resilience levels will be tested. The findings of the study will contribute to the importance and effectiveness of psychological approaches in the treatment of obesity.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy- Based and Motivational Interviewing-Supported Psychoeducation

An 8-week structured psychoeducation program based on cognitive behavioral therapy principles and supported by motivational interviewing techniques.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-25
Primary Completion
2025-06-05
Completion
2025-08-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06632171 on ClinicalTrials.gov